PTPN1 and Hyperglycemia: miRNA-206s inhibitory effects were reversed in the livers upon reintroducing PTPN1, indicating that PTPN1 is involved in mediating the protective effects of miRNA-206 against hyperglycemia and hepatosteatosis (Wu et al., 2017).